drugset / Trial / NCT02465489

Comparison of Deferiprone Extended Release Tablets and Ferriprox Immediate Release Tablets in Healthy Volunteers

NCT02465489

Phase 1 Completed 20 enrolled ApoPharma
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to look at the pharmacokinetics of a new formulation of deferiprone (deferiprone extended release tablets) under fed and fasting conditions.

Timeline

Start
2015-06
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Deferiprone Small molecule 1000 mg

Indications

No indication recorded.